img

Global Prophylactic HIV Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prophylactic HIV Drug Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become the chief contributor to the global burden diseases.
Prophylactic HIV Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prophylactic HIV Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prophylactic HIV Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prophylactic HIV Drug key manufacturers include Gilead Sciences, Merck, Mylan, Cipla, Bristol-Myers Squibb and Roche, etc. Gilead Sciences, Merck, Mylan are top 3 players and held % sales share in total in 2022.
Prophylactic HIV Drug can be divided into Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) and Integrase Inhibitor, etc. Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) is the mainstream product in the market, accounting for % sales share globally in 2022.
Prophylactic HIV Drug is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,, etc. Hospital Pharmacy provides greatest supports to the Prophylactic HIV Drug industry development. In 2022, global % sales of Prophylactic HIV Drug went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prophylactic HIV Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Gilead Sciences
Merck
Mylan
Cipla
Bristol-Myers Squibb
Roche
Segment by Type
Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Integrase Inhibitor

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Prophylactic HIV Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prophylactic HIV Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prophylactic HIV Drug industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Prophylactic HIV Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prophylactic HIV Drug introduction, etc. Prophylactic HIV Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Prophylactic HIV Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Prophylactic HIV Drug Market Overview
1.1 Prophylactic HIV Drug Product Overview
1.2 Prophylactic HIV Drug Market Segment by Type
1.2.1 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
1.2.2 Integrase Inhibitor
1.3 Global Prophylactic HIV Drug Market Size by Type
1.3.1 Global Prophylactic HIV Drug Market Size Overview by Type (2024-2034)
1.3.2 Global Prophylactic HIV Drug Historic Market Size Review by Type (2024-2024)
1.3.3 Global Prophylactic HIV Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prophylactic HIV Drug Sales Breakdown by Type (2024-2024)
1.4.2 Europe Prophylactic HIV Drug Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Prophylactic HIV Drug Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Prophylactic HIV Drug Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Prophylactic HIV Drug Sales Breakdown by Type (2024-2024)
2 Global Prophylactic HIV Drug Market Competition by Company
2.1 Global Top Players by Prophylactic HIV Drug Sales (2024-2024)
2.2 Global Top Players by Prophylactic HIV Drug Revenue (2024-2024)
2.3 Global Top Players by Prophylactic HIV Drug Price (2024-2024)
2.4 Global Top Manufacturers Prophylactic HIV Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prophylactic HIV Drug Market Competitive Situation and Trends
2.5.1 Prophylactic HIV Drug Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prophylactic HIV Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic HIV Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Prophylactic HIV Drug Market
2.8 Key Manufacturers Prophylactic HIV Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prophylactic HIV Drug Status and Outlook by Region
3.1 Global Prophylactic HIV Drug Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Prophylactic HIV Drug Historic Market Size by Region
3.2.1 Global Prophylactic HIV Drug Sales in Volume by Region (2024-2024)
3.2.2 Global Prophylactic HIV Drug Sales in Value by Region (2024-2024)
3.2.3 Global Prophylactic HIV Drug Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Prophylactic HIV Drug Forecasted Market Size by Region
3.3.1 Global Prophylactic HIV Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Prophylactic HIV Drug Sales in Value by Region (2024-2034)
3.3.3 Global Prophylactic HIV Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prophylactic HIV Drug by Application
4.1 Prophylactic HIV Drug Market Segment by Application
4.1.1 Hospital Pharmacy
4.1.2 Retail Pharmacy
4.1.3 Online Pharmacy
4.2 Global Prophylactic HIV Drug Market Size by Application
4.2.1 Global Prophylactic HIV Drug Market Size Overview by Application (2024-2034)
4.2.2 Global Prophylactic HIV Drug Historic Market Size Review by Application (2024-2024)
4.2.3 Global Prophylactic HIV Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prophylactic HIV Drug Sales Breakdown by Application (2024-2024)
4.3.2 Europe Prophylactic HIV Drug Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Prophylactic HIV Drug Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Prophylactic HIV Drug Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Prophylactic HIV Drug Sales Breakdown by Application (2024-2024)
5 North America Prophylactic HIV Drug by Country
5.1 North America Prophylactic HIV Drug Historic Market Size by Country
5.1.1 North America Prophylactic HIV Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Prophylactic HIV Drug Sales in Volume by Country (2024-2024)
5.1.3 North America Prophylactic HIV Drug Sales in Value by Country (2024-2024)
5.2 North America Prophylactic HIV Drug Forecasted Market Size by Country
5.2.1 North America Prophylactic HIV Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Prophylactic HIV Drug Sales in Value by Country (2024-2034)
6 Europe Prophylactic HIV Drug by Country
6.1 Europe Prophylactic HIV Drug Historic Market Size by Country
6.1.1 Europe Prophylactic HIV Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Prophylactic HIV Drug Sales in Volume by Country (2024-2024)
6.1.3 Europe Prophylactic HIV Drug Sales in Value by Country (2024-2024)
6.2 Europe Prophylactic HIV Drug Forecasted Market Size by Country
6.2.1 Europe Prophylactic HIV Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Prophylactic HIV Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Prophylactic HIV Drug by Region
7.1 Asia-Pacific Prophylactic HIV Drug Historic Market Size by Region
7.1.1 Asia-Pacific Prophylactic HIV Drug Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Prophylactic HIV Drug Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Prophylactic HIV Drug Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Prophylactic HIV Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Prophylactic HIV Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prophylactic HIV Drug Sales in Value by Region (2024-2034)
8 Latin America Prophylactic HIV Drug by Country
8.1 Latin America Prophylactic HIV Drug Historic Market Size by Country
8.1.1 Latin America Prophylactic HIV Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Prophylactic HIV Drug Sales in Volume by Country (2024-2024)
8.1.3 Latin America Prophylactic HIV Drug Sales in Value by Country (2024-2024)
8.2 Latin America Prophylactic HIV Drug Forecasted Market Size by Country
8.2.1 Latin America Prophylactic HIV Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prophylactic HIV Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Prophylactic HIV Drug by Country
9.1 Middle East and Africa Prophylactic HIV Drug Historic Market Size by Country
9.1.1 Middle East and Africa Prophylactic HIV Drug Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Prophylactic HIV Drug Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Prophylactic HIV Drug Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Prophylactic HIV Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Prophylactic HIV Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prophylactic HIV Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Gilead Sciences
10.1.1 Gilead Sciences Company Information
10.1.2 Gilead Sciences Introduction and Business Overview
10.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Gilead Sciences Prophylactic HIV Drug Products Offered
10.1.5 Gilead Sciences Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Prophylactic HIV Drug Products Offered
10.2.5 Merck Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Mylan Prophylactic HIV Drug Products Offered
10.3.5 Mylan Recent Development
10.4 Cipla
10.4.1 Cipla Company Information
10.4.2 Cipla Introduction and Business Overview
10.4.3 Cipla Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Cipla Prophylactic HIV Drug Products Offered
10.4.5 Cipla Recent Development
10.5 Bristol-Myers Squibb
10.5.1 Bristol-Myers Squibb Company Information
10.5.2 Bristol-Myers Squibb Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Products Offered
10.5.5 Bristol-Myers Squibb Recent Development
10.6 Roche
10.6.1 Roche Company Information
10.6.2 Roche Introduction and Business Overview
10.6.3 Roche Prophylactic HIV Drug Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Roche Prophylactic HIV Drug Products Offered
10.6.5 Roche Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prophylactic HIV Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prophylactic HIV Drug Industrial Chain Analysis
11.4 Prophylactic HIV Drug Market Dynamics
11.4.1 Prophylactic HIV Drug Industry Trends
11.4.2 Prophylactic HIV Drug Market Drivers
11.4.3 Prophylactic HIV Drug Market Challenges
11.4.4 Prophylactic HIV Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prophylactic HIV Drug Distributors
12.3 Prophylactic HIV Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Table 2. Major Company of Integrase Inhibitor
Table 3. Global Prophylactic HIV Drug Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Prophylactic HIV Drug Sales by Type (2024-2024) & (K Units)
Table 5. Global Prophylactic HIV Drug Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Prophylactic HIV Drug Sales by Type (2024-2024) & (US& Million)
Table 7. Global Prophylactic HIV Drug Market Share in Value by Type (2024-2024)
Table 8. Global Prophylactic HIV Drug Price by Type (2024-2024) & (USD/Unit)
Table 9. Global Prophylactic HIV Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Prophylactic HIV Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Prophylactic HIV Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Prophylactic HIV Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Prophylactic HIV Drug Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Prophylactic HIV Drug Sales by Type (2024-2024) & (K Units)
Table 15. North America Prophylactic HIV Drug Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Prophylactic HIV Drug Sales (K Units) by Type (2024-2024)
Table 17. Europe Prophylactic HIV Drug Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Prophylactic HIV Drug Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Prophylactic HIV Drug Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Prophylactic HIV Drug Sales (K Units) by Type (2024-2024)
Table 21. Latin America Prophylactic HIV Drug Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Prophylactic HIV Drug Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Prophylactic HIV Drug Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Prophylactic HIV Drug Sales by Company (2024-2024) & (K Units)
Table 25. Global Prophylactic HIV Drug Sales Share by Company (2024-2024)
Table 26. Global Prophylactic HIV Drug Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Prophylactic HIV Drug Revenue Share by Company (2024-2024)
Table 28. Global Market Prophylactic HIV Drug Price by Company (2024-2024) & (USD/Unit)
Table 29. Global Prophylactic HIV Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Prophylactic HIV Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic HIV Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Prophylactic HIV Drug Market
Table 33. Key Manufacturers Prophylactic HIV Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Prophylactic HIV Drug Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Prophylactic HIV Drug Sales by Region (2024-2024) & (K Units)
Table 37. Global Prophylactic HIV Drug Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Prophylactic HIV Drug Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Prophylactic HIV Drug Sales Market Share in Value by Region (2024-2024)
Table 40. Global Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 41. Global Prophylactic HIV Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Prophylactic HIV Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Prophylactic HIV Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Prophylactic HIV Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Prophylactic HIV Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Prophylactic HIV Drug Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Prophylactic HIV Drug Sales by Application (2024-2024) & (K Units)
Table 48. Global Prophylactic HIV Drug Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Prophylactic HIV Drug Sales Market Share in Value by Application (2024-2024)
Table 51. Global Prophylactic HIV Drug Price by Application (2024-2024) & (USD/Unit)
Table 52. Global Prophylactic HIV Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Prophylactic HIV Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Prophylactic HIV Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Prophylactic HIV Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Prophylactic HIV Drug Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Prophylactic HIV Drug Sales by Application (2024-2024) (K Units)
Table 58. North America Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Prophylactic HIV Drug Sales by Application (2024-2024) (K Units)
Table 60. Europe Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Prophylactic HIV Drug Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Prophylactic HIV Drug Sales by Application (2024-2024) (K Units)
Table 64. Latin America Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Prophylactic HIV Drug Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Prophylactic HIV Drug Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Prophylactic HIV Drug Sales by Country (2024-2024) & (K Units)
Table 68. North America Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Prophylactic HIV Drug Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2024)
Table 71. North America Prophylactic HIV Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Prophylactic HIV Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Prophylactic HIV Drug Sales by Country (2024-2024) & (K Units)
Table 76. Europe Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Prophylactic HIV Drug Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Prophylactic HIV Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Prophylactic HIV Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Prophylactic HIV Drug Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Prophylactic HIV Drug Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Prophylactic HIV Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Prophylactic HIV Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Prophylactic HIV Drug Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Prophylactic HIV Drug Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Prophylactic HIV Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Prophylactic HIV Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Prophylactic HIV Drug Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Prophylactic HIV Drug Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Prophylactic HIV Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Prophylactic HIV Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Gilead Sciences Company Information
Table 108. Gilead Sciences Introduction and Business Overview
Table 109. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 110. Gilead Sciences Prophylactic HIV Drug Product
Table 111. Gilead Sciences Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Merck Prophylactic HIV Drug Product
Table 116. Merck Recent Development
Table 117. Mylan Company Information
Table 118. Mylan Introduction and Business Overview
Table 119. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Mylan Prophylactic HIV Drug Product
Table 121. Mylan Recent Development
Table 122. Cipla Company Information
Table 123. Cipla Introduction and Business Overview
Table 124. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Cipla Prophylactic HIV Drug Product
Table 126. Cipla Recent Development
Table 127. Bristol-Myers Squibb Company Information
Table 128. Bristol-Myers Squibb Introduction and Business Overview
Table 129. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Bristol-Myers Squibb Prophylactic HIV Drug Product
Table 131. Bristol-Myers Squibb Recent Development
Table 132. Roche Company Information
Table 133. Roche Introduction and Business Overview
Table 134. Roche Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Roche Prophylactic HIV Drug Product
Table 136. Roche Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Prophylactic HIV Drug Market Trends
Table 140. Prophylactic HIV Drug Market Drivers
Table 141. Prophylactic HIV Drug Market Challenges
Table 142. Prophylactic HIV Drug Market Restraints
Table 143. Prophylactic HIV Drug Distributors List
Table 144. Prophylactic HIV Drug Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Prophylactic HIV Drug Product Picture
Figure 2. Global Prophylactic HIV Drug Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prophylactic HIV Drug Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Prophylactic HIV Drug Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Figure 6. Global Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Integrase Inhibitor
Figure 8. Global Integrase Inhibitor Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Prophylactic HIV Drug Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Prophylactic HIV Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Prophylactic HIV Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Prophylactic HIV Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Prophylactic HIV Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Prophylactic HIV Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Prophylactic HIV Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Prophylactic HIV Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Prophylactic HIV Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Prophylactic HIV Drug Revenue in 2022
Figure 23. Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital Pharmacy
Figure 25. Global Hospital Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Retail Pharmacy
Figure 27. Global Retail Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Online Pharmacy
Figure 29. Global Online Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Prophylactic HIV Drug Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Prophylactic HIV Drug Sales Market Share by Application in 2022 & 2034
Figure 32. North America Prophylactic HIV Drug Sales Market Share in Volume by Application in 2022
Figure 33. North America Prophylactic HIV Drug Sales Market Share in Value by Application in 2022
Figure 34. Europe Prophylactic HIV Drug Sales Market Share in Volume by Application in 2022
Figure 35. Europe Prophylactic HIV Drug Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Prophylactic HIV Drug Sales Market Share in Value by Application in 2022
Figure 38. Latin America Prophylactic HIV Drug Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Prophylactic HIV Drug Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Prophylactic HIV Drug Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Prophylactic HIV Drug Manufacturing Cost Structure
Figure 43. Prophylactic HIV Drug Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries